Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D, Park SW
This makes it a valuable treatment option for many individuals living with the condition, as cardiovascular disease is a common and serious complication of diabetes
In a recent online survey, N = 600 patients with T2D were asked to provide their treatment preferences regarding a once-daily oral GLP-1RA compared with a once-weekly injectable GLP-1RA
arthralgia is recognised in approved incretin therapies but has not been prominently characterised for retatrutide pending Phase 3 results
Esta propiedad es especialmente interesante en el contexto del tratamiento de la obesidad, ya que favorece la reduccin de la masa grasa sin comprometer la masa magra
FDA-approved semaglutide is sold under the brand names Ozempic (for diabetes) and Wegovy (for weight management)